Medical Decision Making: Drug Therapy Requiring Intensive Monitoring for Toxicity

There are often questions and confusion on what is included and acceptable when choosing “Drug therapy requiring intensive monitoring for toxicity” in the Medical Decision-Making Risk category for Evaluation and Management coding. This article reviews the definition and guidelines as provided by CMS and their Medicare Administrative Contractors (MACs). Risk: High MDM – Drug therapy…

ROI FROM HUMANA PRIOR AUTHORIZATION PLATFORM DRIVES NATIONWIDE EXPANSION IN LESS THAN ONE YEAR

The ROI from Humana prior authorization platform is driving a nationwide expansion in less than one year. This expansion will improve healthcare processes and costs. Continue reading below to learn more! “This is a re-imagined PA process, one where expedited approval becomes the standard,” says one Humana executive. KEY TAKEAWAYS Humana’s prior authorization platform authorizes…